{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:00:36Z","timestamp":1793916036072,"version":"4.8.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"\n Importance<\/jats:title>\n People with HIV are living longer due to improvements in antiretroviral therapy over the last 2 decades. Current age-specific estimates of cancer risk among people with HIV may inform cancer prevention and clinical guidelines for this population.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To estimate cancer incidence rates (IRs) using a population-based linkage of HIV and cancer registries.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This population-based cohort study used data from 12 US states, Washington, DC, and Puerto Rico from 2001 to 2019. People with HIV and the general population in the HIV\/AIDS Cancer Match Study were included in the analysis, which occurred between October 2023 and December 2024.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Age-standardized IRs (per 100\u202f000 person-years) were calculated across calendar periods (2001 to 2004, 2005 to 2009, 2010 to 2014, and 2015 to 2019) and incidence rate ratios (IRRs) across calendar periods using adjusted Poisson regression. Standardized incidence ratios (SIRs) were estimated for 2010 to 2014 and 2015 to 2019, and age group\u2013specific cancer incidence and SIRs were estimated for 2010 to 2019.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The analysis included 7.2 million person-years among 847\u202f107 people with HIV (5.3 million person-years among males [73%]). Comparing years 2015 to 2019 to years 2010 to 2014, incidence of diffuse large B-cell lymphoma (DLBCL) decreased 23% (IRR, 0.77; 95% CI, 0.70-0.84), Kaposi sarcoma (KS) decreased 24% (IRR, 0.76; 95% CI, 0.69-0.84), Hodgkin lymphoma decreased 25% (IRR, 0.75; 95% CI, 0.65-0.86), and cancers of the lung decreased 17% (IRR, 0.83; 95% CI, 0.77-0.90) and liver decreased 25% (IRR, 0.75; 95% CI, 0.67-0.84). Among people with HIV aged 70 to 84 years, IRs were highest for cancers of the prostate (448.01; 95% CI, 404.26-495.20), lung (269.79; 95% CI, 240.86-301.24), female breast (202.29; 95% CI, 155.79-258.32), liver (82.82; 95% CI, 67.16-101.03), and colon (107.57; 95% CI, 89.61-128.08), exceeding the IRs for DLBCL (41.83; 95% CI, 30.95-55.31) and KS (15.37; 95% CI, 9.11-24.29). From 2015 to 2019, risk remained significantly elevated in people with HIV for several cancer types, including KS (SIR, 213.87; 95% CI, 198.81-229.73), Hodgkin lymphoma (SIR, 6.29; 95% CI, 5.68-6.94), DLBCL (SIR, 5.25; 95% CI, 5.25-6.01), cancers of the anus (SIR, 17.07; 95% CI, 16.01-18.17), vulva (SIR, 11.40; 95% CI, 9.60-13.44), liver (SIR, 1.89; 95% CI, 1.74-2.05), and lung (SIR, 1.59; 95% CI, 1.51-1.68). For nearly all these cancers, SIRs significantly declined with increasing age.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study, significant declines in the incidence and relative risk for cancers among people with HIV demonstrate continued progress in HIV treatment and cancer prevention. These estimates may provide insight into the priorities for prevention and early detection of cancer as the population of people with HIV enters ages with greater risk for cancer.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaoncol.2025.1589","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T11:00:57Z","timestamp":1749726057000},"page":"855","source":"Crossref","is-referenced-by-count":31,"title":["Cancer Incidence and Trends in US Adults With HIV"],"prefix":"10.1001","volume":"11","author":[{"given":"Cameron B.","family":"Haas","sequence":"first","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"McGee-Avila","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianlai","family":"Luo","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Gershman","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Cherala","sequence":"additional","affiliation":[{"name":"Massachusetts Department of Public Health, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colby","family":"Cohen","sequence":"additional","affiliation":[{"name":"Florida Department of Health, Bureau of Communicable Diseases, Tallahassee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analise","family":"Monterosso","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Archer","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, Austin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum Z.","family":"Insaf","sequence":"additional","affiliation":[{"name":"New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Engels","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith S.","family":"Shiels","sequence":"additional","affiliation":[{"name":"National Cancer Institute, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"coi250024r1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12879-017-2254-7","article-title":"Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012.","volume":"17","author":"Eyawo","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"8","key":"coi250024r2","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1086\/656416","article-title":"Cancer as a cause of death among people with AIDS in the United States.","volume":"51","author":"Simard","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"9","key":"coi250024r3","doi-asserted-by":"publisher","first-page":"e224","DOI":"10.1093\/cid\/ciaa1016","article-title":"Deaths attributable to cancer in the US human immunodeficiency virus population during 2001-2015.","volume":"72","author":"Horner","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"12","key":"coi250024r4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030.","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"issue":"11","key":"coi250024r5","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","article-title":"Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study.","volume":"4","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"Lancet HIV"},{"issue":"4","key":"coi250024r6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/QAD.0000000000001721","article-title":"Cancer burden attributable to cigarette smoking among HIV-infected people in North America.","volume":"32","author":"Altekruse","year":"2018","journal-title":"AIDS"},{"issue":"7","key":"coi250024r7","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jis458","article-title":"Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa Rica.","volume":"206","author":"Castro","year":"2012","journal-title":"J Infect Dis"},{"issue":"20","key":"coi250024r8","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/jnci\/djq366","article-title":"Improved estimates of cancer-specific survival rates from population-based data.","volume":"102","author":"Howlader","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"coi250024r9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<791::AID-SIM500>3.0.CO;2-#","article-title":"Confidence intervals for directly standardized rates: a method based on the gamma distribution.","volume":"16","author":"Fay","year":"1997","journal-title":"Stat Med"},{"issue":"9","key":"coi250024r10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1158\/1055-9965.EPI-21-0008","article-title":"Kaposi sarcoma incidence, burden, and prevalence in United States people with HIV, 2000-2015.","volume":"30","author":"Peprah","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"coi250024r11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.29497","article-title":"Trends in epidemiology of esophageal cancer in the US, 1975-2018.","volume":"6","author":"Rodriguez","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"coi250024r12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study.","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"issue":"11","key":"coi250024r13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/QAD.0000000000001112","article-title":"Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997-2012.","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"issue":"14","key":"coi250024r14","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/cancers15143640","article-title":"Trends in cancer incidence in different antiretroviral treatment-eras amongst people with HIV.","volume":"15","author":"Greenberg","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"coi250024r15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/hiv.12584","article-title":"The world-wide incidence of Kaposi\u2019s sarcoma in the HIV\/AIDS era.","volume":"19","author":"Liu","year":"2018","journal-title":"HIV Med"},{"issue":"3","key":"coi250024r16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/QAD.0000000000003770","article-title":"Real-world use of antiretroviral therapy and risk of cancer among people with HIV in Texas.","volume":"38","author":"Horner","year":"2024","journal-title":"AIDS"},{"issue":"4","key":"coi250024r18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/QAI.0000000000000489","article-title":"Impact of age on retention in care and viral suppression.","volume":"68","author":"Yehia","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"coi250024r19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jnci\/djad172","article-title":"Risk of hepatocellular carcinoma in people with HIV in the United States, 2001-2019.","volume":"116","author":"McGee-Avila","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"coi250024r21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/QAD.0000000000000922","article-title":"Prevalence of non-HIV cancer risk factors in persons living with HIV\/AIDS: a meta-analysis.","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"},{"issue":"10","key":"coi250024r22","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1016\/S2352-3018(22)00219-3","article-title":"Trends and risk of lung cancer among people living with HIV in the USA: a population-based registry linkage study.","volume":"9","author":"Haas","year":"2022","journal-title":"Lancet HIV"},{"issue":"5","key":"coi250024r23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00126334-200304150-00010","article-title":"Immune deficiency and risk for malignancy among persons with AIDS.","volume":"32","author":"Mbulaiteye","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"coi250024r24","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae652","article-title":"HIV-1 viremia and cancer risk in 2.8 million people: the South African HIV Cancer Match Study.","author":"Ruffieux","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"10","key":"coi250024r25","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/jnci\/djad128","article-title":"Cumulative incidence of anal cancer since HIV or AIDS diagnosis in the United States.","volume":"115","author":"Haas","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi250024r26","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type.","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"11","key":"coi250024r27","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1080\/09540121.2024.2383875","article-title":"Incidence of prostate cancer in Medicaid beneficiaries with and without HIV in 2001-2015 in 14 states.","volume":"36","author":"Pirsl","year":"2024","journal-title":"AIDS Care"},{"issue":"1","key":"coi250024r28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QAI.0000000000003318","article-title":"Comparing cancer incidence in an observational cohort of Medicaid beneficiaries with and without HIV, 2001-2015.","volume":"95","author":"Rudolph","year":"2024","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5","key":"coi250024r29","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae246","article-title":"Incidence of colon cancer among Medicaid beneficiaries with or without human immunodeficiency virus under comparable colorectal cancer screening patterns.","volume":"11","author":"Rudolph","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"coi250024r30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jnci\/djy010","article-title":"Risk of breast, prostate, and colorectal cancer diagnoses among HIV-infected individuals in the United States.","volume":"110","author":"Coghill","year":"2018","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"coi250024r31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1158\/1055-9965.EPI-24-0137","article-title":"Prostate cancer diagnosis rates among insured men with and without HIV in South Africa: a cohort study.","volume":"33","author":"Ruffieux","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"coi250024r32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/JU.0000000000002249","article-title":"Prostate cancer screening and incidence among aging persons living with HIV.","volume":"207","author":"Leapman","year":"2022","journal-title":"J Urol"},{"issue":"3","key":"coi250024r33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3390\/cancers16030546","article-title":"Cancer and HIV: the molecular mechanisms of the deadly duo.","volume":"16","author":"Omar","year":"2024","journal-title":"Cancers (Basel)"},{"key":"coi250024r34","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae479","article-title":"Primary care guidance for providers of care for persons with human immunodeficiency virus: 2024 update by the HIV Medicine Association of the Infectious Diseases Society of America.","author":"Horberg","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"12","key":"coi250024r35","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae662","article-title":"High rates of high-risk HPV anal infection and abnormal cytology in a cohort of transgender people assigned male at birth.","volume":"11","author":"Harfouch","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"coi250024r36","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3390\/v15051170","article-title":"HPV infection of the oropharyngeal, genital and anal mucosa and associated dysplasia in people living with HIV.","volume":"15","author":"Hidalgo-Tenorio","year":"2023","journal-title":"Viruses"},{"key":"coi250024r37","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126644","article-title":"HPV vaccination and anal HPV infection in gay, bisexual, and other men who have sex with men.","volume":"45","author":"Kassam","year":"2025","journal-title":"Vaccine"},{"issue":"8","key":"coi250024r38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1473-3099(19)30164-1","article-title":"Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis.","volume":"19","author":"Lin","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"coi250024r39","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ntr\/ntaa277","article-title":"National estimates of prevalence, time-trend, and correlates of smoking in US people living with HIV (NHANES 1999-2016).","volume":"23","author":"Asfar","year":"2021","journal-title":"Nicotine Tob Res"},{"key":"coi250024r40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ypmed.2018.03.007","article-title":"Trends in cigarette smoking among adults with HIV compared with the general adult population, United States - 2009-2014.","volume":"111","author":"Frazier","year":"2018","journal-title":"Prev Med"},{"issue":"12","key":"coi250024r41","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1093\/ntr\/ntw126","article-title":"Smoking cessation for people living with HIV\/AIDS: a literature review and synthesis.","volume":"18","author":"Ledgerwood","year":"2016","journal-title":"Nicotine Tob Res"},{"issue":"8","key":"coi250024r42","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/cid\/ciab434","article-title":"High prevalence of anal high-grade squamous intraepithelial lesions, and prevention through human papillomavirus vaccination, in young men who have sex with men living with human immunodeficiency virus.","volume":"73","author":"Palefsky","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"coi250024r43","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/ijc.34850","article-title":"International Anal Neoplasia Society\u2019s consensus guidelines for anal cancer screening.","volume":"154","author":"Stier","year":"2024","journal-title":"Int J Cancer"},{"issue":"1","key":"coi250024r44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnci\/djad176","article-title":"Severe anal intraepithelial neoplasia trends and subsequent invasive anal cancer in the United States.","volume":"116","author":"Haas","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"coi250024r45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ijc.34727","article-title":"State of the science and future directions for research on HIV and cancer: summary of a joint workshop sponsored by IARC and NCI.","volume":"154","author":"Engels","year":"2024","journal-title":"Int J Cancer"},{"issue":"14","key":"coi250024r46","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.2011.396","article-title":"Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.","volume":"305","author":"Shiels","year":"2011","journal-title":"JAMA"},{"key":"coi250024r17","unstructured":"Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data\u2014United States and 6 territories and freely associated states, 2022. CDC Stacks. May 21, 2024. Accessed May 8, 2025. https:\/\/stacks.cdc.gov\/view\/cdc\/156511"},{"key":"coi250024r20","unstructured":"National Cancer Institute. Cancer Trends Progress Report. Accessed December 14, 2024. https:\/\/progressreport.cancer.gov"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2835050\/jamaoncology_haas_2025_oi_250024_1755187165.21907.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T15:00:47Z","timestamp":1755788447000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2835050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2025.1589","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,1]]}}}